Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Sanyuan Biotechnology is a leading global producer of erythritol, a zero-calorie sugar substitute produced through microbial fermentation. Based in Binzhou, China, the company specializes in the research, development, and industrial-scale production of sugar alcohols and functional sweeteners. Their product portfolio includes erythritol, allulose, and various sweetener blends used extensively in the food, beverage, and pharmaceutical industries. As a major supplier to global brands, the company leverages advanced fermentation technology to provide high-purity, non-GMO alternatives to traditional sugar. The company is publicly traded on the Shenzhen Stock Exchange and maintains a dominant position in the international erythritol market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Sanyuan Biotechnology.